Distribution of carbapenem resistance mechanisms in clinical isolates of XDR Pseudomonas aeruginosa

Our study aims to define the epidemiology of carbapenem resistance mechanisms in clinical isolates of Pseudomonas aeruginosa (PA). We evaluated 11,457 clinical PA strains isolated between 2009 and 2015 at the tertiary care University Hospital in Heidelberg, Germany. Thirty-four percent of the isolat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: De Rosa, Annalisa (VerfasserIn) , Mutters, Nico T. (VerfasserIn) , Mastroianni, Claudio M. (VerfasserIn) , Kaiser, Stefan J. (VerfasserIn) , Günther, Frank (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 31 May 2019
In: European journal of clinical microbiology & infectious diseases
Year: 2019, Jahrgang: 38, Heft: 8, Pages: 1547-1552
ISSN:1435-4373
DOI:10.1007/s10096-019-03585-0
Online-Zugang:Verlag, Volltext: https://doi.org/10.1007/s10096-019-03585-0
Volltext
Verfasserangaben:Annalisa De Rosa, Nico T. Mutters, Claudio M. Mastroianni, Stefan J. Kaiser, Frank Günther

MARC

LEADER 00000caa a2200000 c 4500
001 1688008853
003 DE-627
005 20230427215437.0
007 cr uuu---uuuuu
008 200122s2019 xx |||||o 00| ||eng c
024 7 |a 10.1007/s10096-019-03585-0  |2 doi 
035 |a (DE-627)1688008853 
035 |a (DE-599)KXP1688008853 
035 |a (OCoLC)1341298765 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a De Rosa, Annalisa  |e VerfasserIn  |0 (DE-588)1163634115  |0 (DE-627)1027960847  |0 (DE-576)508117690  |4 aut 
245 1 0 |a Distribution of carbapenem resistance mechanisms in clinical isolates of XDR Pseudomonas aeruginosa  |c Annalisa De Rosa, Nico T. Mutters, Claudio M. Mastroianni, Stefan J. Kaiser, Frank Günther 
264 1 |c 31 May 2019 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 22.01.2020 
520 |a Our study aims to define the epidemiology of carbapenem resistance mechanisms in clinical isolates of Pseudomonas aeruginosa (PA). We evaluated 11,457 clinical PA strains isolated between 2009 and 2015 at the tertiary care University Hospital in Heidelberg, Germany. Thirty-four percent of the isolates (3867/11,457) were MDR (multidrug-resistant), 16% (1816/11,457) were XDR (extensively drug resistant), and less than 1% (82/11,457) had a PDR (pandrug-resistant) profile. Of those, 23% carried a carbapenemase gene (CPM positive) with 12% VIM-2, 10% VIM-1, and less than 1% IMP-1. Comparing MIC (minimal inhibitory concentration) distributions, the mean rank for meropenem, imipenem, gentamicin, and fosfomycin was significantly higher in the CPM-positive group than in the CPM-negative XDR group (p ≤ 0.004). oprD (outer membrane protein) mutations were found in 19/19 tested strains; 12/19 carried a CPM and had a higher mutation rate. Meropenem resistance was mostly associated with the presence of CPM. Only 1/19 strains was meropenem resistant in the absence of CPM genes; nevertheless, it carried an oprD mutation in a strategic site (loop 2). Of 19 CPM-negative strains tested, 7 (36%) showed EP (efflux pumps) hyperexpression versus 12 in the CPM-positive strains. In our study, nearly 50% of the PA isolates exhibited resistance to the tested first-line antibiotics. Our study also demonstrates that carbapenemase genes can be isolated in approximately 23% of XDR PA strains in our population. This finding supports the clinical relevance of PA driven by the possible presence of multiple resistance mechanisms acquired under exposure to antibiotics or by horizontal transfer of resistance genes. 
650 4 |a Carbapenemases 
650 4 |a Efflux pumps 
650 4 |a MDR 
650 4 |a oprD 
650 4 |a Pseudomonas aeruginosa 
650 4 |a XDR 
700 1 |a Mutters, Nico T.  |d 1980-  |e VerfasserIn  |0 (DE-588)136849687  |0 (DE-627)694710199  |0 (DE-576)288598962  |4 aut 
700 1 |a Mastroianni, Claudio M.  |e VerfasserIn  |4 aut 
700 1 |a Kaiser, Stefan J.  |e VerfasserIn  |0 (DE-588)1162798734  |0 (DE-627)1027258042  |0 (DE-576)507607937  |4 aut 
700 1 |a Günther, Frank  |d 1982-  |e VerfasserIn  |0 (DE-588)138444935  |0 (DE-627)602589037  |0 (DE-576)307130355  |4 aut 
773 0 8 |i Enthalten in  |t European journal of clinical microbiology & infectious diseases  |d Berlin : Springer, 1982  |g 38(2019), 8, Seite 1547-1552  |h Online-Ressource  |w (DE-627)25372273X  |w (DE-600)1459049-9  |w (DE-576)072372575  |x 1435-4373  |7 nnas  |a Distribution of carbapenem resistance mechanisms in clinical isolates of XDR Pseudomonas aeruginosa 
773 1 8 |g volume:38  |g year:2019  |g number:8  |g pages:1547-1552  |g extent:6  |a Distribution of carbapenem resistance mechanisms in clinical isolates of XDR Pseudomonas aeruginosa 
856 4 0 |u https://doi.org/10.1007/s10096-019-03585-0  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20200122 
993 |a Article 
994 |a 2019 
998 |g 138444935  |a Günther, Frank  |m 138444935:Günther, Frank  |d 50000  |e 50000PG138444935  |k 0/50000/  |p 5  |y j 
998 |g 1162798734  |a Kaiser, Stefan J.  |m 1162798734:Kaiser, Stefan J.  |p 4 
998 |g 136849687  |a Mutters, Nico T.  |m 136849687:Mutters, Nico T.  |d 910000  |d 911700  |e 910000PM136849687  |e 911700PM136849687  |k 0/910000/  |k 1/910000/911700/  |p 2 
998 |g 1163634115  |a De Rosa, Annalisa  |m 1163634115:De Rosa, Annalisa  |p 1  |x j 
999 |a KXP-PPN1688008853  |e 3578545392 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"roleDisplay":"VerfasserIn","display":"De Rosa, Annalisa","role":"aut","family":"De Rosa","given":"Annalisa"},{"given":"Nico T.","family":"Mutters","role":"aut","display":"Mutters, Nico T.","roleDisplay":"VerfasserIn"},{"family":"Mastroianni","given":"Claudio M.","display":"Mastroianni, Claudio M.","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Stefan J.","family":"Kaiser","role":"aut","roleDisplay":"VerfasserIn","display":"Kaiser, Stefan J."},{"given":"Frank","family":"Günther","role":"aut","display":"Günther, Frank","roleDisplay":"VerfasserIn"}],"title":[{"title":"Distribution of carbapenem resistance mechanisms in clinical isolates of XDR Pseudomonas aeruginosa","title_sort":"Distribution of carbapenem resistance mechanisms in clinical isolates of XDR Pseudomonas aeruginosa"}],"recId":"1688008853","language":["eng"],"note":["Gesehen am 22.01.2020"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Annalisa De Rosa, Nico T. Mutters, Claudio M. Mastroianni, Stefan J. Kaiser, Frank Günther"]},"id":{"eki":["1688008853"],"doi":["10.1007/s10096-019-03585-0"]},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"31 May 2019"}],"relHost":[{"note":["Gesehen am 05.12.05"],"disp":"Distribution of carbapenem resistance mechanisms in clinical isolates of XDR Pseudomonas aeruginosaEuropean journal of clinical microbiology & infectious diseases","type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"25372273X","language":["eng"],"pubHistory":["1.1982 -"],"part":{"extent":"6","text":"38(2019), 8, Seite 1547-1552","volume":"38","pages":"1547-1552","issue":"8","year":"2019"},"titleAlt":[{"title":"European journal of clinical microbiology and infectious diseases"},{"title":"European journal of clinical microbiology"}],"title":[{"title":"European journal of clinical microbiology & infectious diseases","title_sort":"European journal of clinical microbiology & infectious diseases"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"1982-","publisher":"Springer","dateIssuedKey":"1982","publisherPlace":"Berlin ; Heidelberg ; New York"}],"id":{"issn":["1435-4373"],"zdb":["1459049-9"],"eki":["25372273X"]}}],"physDesc":[{"extent":"6 S."}]} 
SRT |a DEROSAANNADISTRIBUTI3120